EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)

Similar documents
Out-Patient Billing CPT Codes

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

August 17, Dear Valued Client:

Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota

Specimen Collection Requirements. Test Name Specimen Type Storage Time Storage Conditions

The Center for PERSONALIZED DIAGNOSTICS

Objectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

Oxford BRC Haemato-Molecular Diagnostic Service

Russell-Silver syndrome (RSS)

Case 1. Sa A.Wang, MD UT MD Anderson Cancer Center Houston, TX

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)

HEMATOPATHOLOGY SERVICES

CPAL and GenPath Flow Cytometry Specimen Handling

Molecular Diagnostics Centre

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011.

NeoTYPE Cancer Profiles

New Test Announcements

Illumina Trusight Myeloid Panel validation A R FHAN R A FIQ

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Providence Medford Medical Center Pathology Department

Testing for Fabry Disease. What You Need to Know

Cost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic

Test Definition: LCMS Leukemia/Lymphoma Immunophenotyping by Flow Cytometry

ADRL Advanced Diagnostics Research Laboratory

Initial Diagnostic Workup of Acute Leukemia

Molecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang

molecular oncology services

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR;

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

Blastic Plasmacytoid Dendritic Cell Neoplasm with DNMT3A and TET2 mutations (SH )

October Billing and compliance. Coagulation. Immunohistochemistry. Immunology. Referral testing ICD 10

West Midlands Regional Genetics Laboratory

Your single-source laboratory solution. FISH Probe Library

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING

The spectrum of flow cytometry of the bone marrow

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D.

Role of FISH in Hematological Cancers

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

CLL Complete SM Report

Hematopathology Associates, LLC.

METABOLITE TEST REQUISITION FORM SPECIMEN INFORMATION. Specimen Date: Time: ADDITIONAL INFORMATION

Laboratory Service Report

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

NeoTYPE Cancer Profiles

METABOLITE TEST REQUISITION FORM

Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms

Expertise Reliability Service

TELEFAX. Toxoplasma Serology Laboratory (TSL) DATE: TO: FAX: FROM:

Molecular Advances in Hematopathology

NEHODS - Northern England Haemato-Oncology Diagnostic Service

Krishna Reddy CH and Ashwin Dalal. Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

Please Silence Your Cell Phones. Thank You

Disclosure: Objectives/Outline. Leukemia: Genealogy of Pathology Practice: Old Diseases New Expectations. Nothing to disclose.

ACMG/CAP Cytogenetics CY

Test Name Results Units Bio. Ref. Interval. Positive

PROCEDURES FOR COLLECTING SHIPPING SPECIMENS FOR MEASUREMENT OF NICOTINE, COTININE, CAFFEINE AND CATECHOLAMINES 2017

Hematopathology Case Study

Test Name Results Units Bio. Ref. Interval. Positive

[COMPREHENSIVE GENETIC ASSAY PANEL ON

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

Molecular Genetic Testing for the Diagnosis of Haematological Malignancies

Registration & Shipment Manual

JAK2 V617F analysis. Indication: monitoring of therapy

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD


WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities

SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT


Laboratory Service Report

Welcome and Introductions

EMORY NEUROMUSCULAR LABORATORY

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Next Generation Sequencing in Haematological Malignancy: A European Perspective. Wolfgang Kern, Munich Leukemia Laboratory

Therapy-related MDS/AML with KMT2A (MLL) Rearrangement Following Therapy for APL Case 0328

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

Current Techniques in Molecular Biology Friedel Nollet, Ph.D.

20/20 PATHOLOGY REPORTS

University of Utah. Cutaneous Nerve Evaluation. Please read through all information BEFORE scheduling patient s biopsy

Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms

MRD detection in AML. Adriano Venditti Hematology Fondazione Policlinico Tor Vergata Rome

Coding Training Guide (V5) Effective Date: 7/26/2012

Examining Genetics and Genomics of Acute Myeloid Leukemia in 2017

Molecular Diagnostics of Myeloid and Lymphoid Neoplasms

September 04, 2008

Update on the WHO Classification of Acute Myeloid Leukemia. Kaaren K. Reichard, MD Mayo Clinic Rochester

Lab Guide 2018 Diagnostic Genomic Division(DGD)

BreenLab - Molecular Cytogenetic Investigation of Soft Tissue Sarcoma General information and sample submission requirements

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Specimen Submission Guide

School of Pathology and Laboratory Medicine: Current and New Research Interests

Molecular Detection of BCR/ABL1 for the Diagnosis and Monitoring of CML

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Specimen Collection. Urine Vacutainers. Laboratory Services September 2018

Transcription:

THE UNIVERSITY OF TEXAS *Required Fields PHYSICIAN! FACILITY/ CLIENT INFORMATION MDAndersonefief &ter MaltgararEettcy 'REQUESTING PHYSICIAN Division of Pathology! Laboratory Medicine Services Test Requisition SHIP MICROBIOLOGY, FLOW CYTOMETRY, HLA AND CYTOGENETICS TESTING TO: 1515 Holcombe Blvd., R4.1446 (Unit 72) Houston, Texas 773 PHONE: (713) 794193 OR 194 FAX: (713) 745-1994 CONTINENTAL US: 1-8-315-8424 'PHONE EXT ADDRESS HOSPITAL / OFFICE STATE ZIP PATIENT INFORMAllON LAST NAME FIRST NAME DOB ID NUMBER PT. PHONE SSN SHIP MOLECULAR TESTING ONLY TO: PT. ADDRESS INSURANCE PROVIDER / WAX CITY 6565 MD Anderson Blvd., Room Z3.423 Houston TX 773 Phone: (713) 794-478 / Fax: (713) 563-31 SPECIMEN INFORMATION: Collection Date: *UPIN / NPI NUMBER / CITY SEX STATE ZIP POLICY NUMBER Time: PHONE NUMBER A/P Specimen Type: Serum Plasma BM Urine PB Other Diagnosis: MICROBIOLOGY CMV Antigenemia Glactornanan (Aspergillus Ag) MOLECULAR DIAGNOSTICS LeukemialLymphoma Testing with Intern and Report FLOW CYTOMETRY Acute Leukemia Screen Panel 8-CLUB-Cell Lymphoma Panel Limited B-CLL Panel (CD5/CD19/CD38, kappa, lambda) Hairy Cell Leukemia Panel Myeloma Panel Waldenstrom's Panel T-Cell Lymphoma/Mycosis Fungoides (ME) Panel Immunodeficiency Panel CD41CD8 ratio (PB only) Transplant Panel CD34 Assay Other Markers Please speck Clonality Ass TCR-betafT-cell clonality (PCR) TCR-gammalT-cell clonality (PCR) IGH/B-cell cionaliry (PCR) TransiocationiGene Fusions ABL I mutation (full kinase domain sequencing) ABL1 quantitative sequencing (oodons 311-317/including T3151) Acute myeloid/lymphoid leukemia translocation screen: BCR-AS!,; PML-k4RA ; Rtlial-RUNX1T1 ; ETV6-RUNX1 ; E24-PBX1 ; MLL-AF4 ; CBFB-MYRI A,D,E ; DEK-CAN t(9:22)bcr-abl 1_Major (quant PCR) (e13a2(b2a2), (e14a2(b3a2) t(9;22)bcr-abl _Minor (quant PCR) (e1a2) HISTOCOIWATIBIUTY -HLA DONOR TYPING HLA Class 1 Molecular KA Class II Molecular KIT mutation ( exon 17) El KRAS mutation (oodons 12, 13, 61) NRAS mutation (codons 12, 13,61) MPL mutation (codon 515) NPM1 mutation MYD88 mutation (codon 265) Transplant Studies with Interp and Report DONOR INFORMATION Post-Transplant Quantitative Chimerism Analysis: Last Name: First Name: DOB: Sex: 55N or passport* Relationship to Patient: BCR-ABL -1(9;22)_Altemative Transcript (quant PCR) (e13a2(b2a2), e14a2(b3a2), e1a2, e13 a3(b2a3), e14a3(b3a3),e1a3) F/Pal/PDGFRA Inv 16 (quant PCR) k8;21) (quant PCR) t(11;14)mtc(quantpcr) f(14;18) MBR (quant PCR) t(14,18) MCR (quant PCR t(15;17) (quant PCR) Mutations (Point Mutations, Insertions, Deletions) CALR mutation (axon 9) CEBPA mutation CSF3R mutation (exon 14, 17) IDH1 mutation (codon 132) IDH2 mutation (codon 14, 172) JAK2 Exon 12 mutation JAK2 mutation (codon 617) PATIENT TYPING HLA- Class I, Molecular [21] HLA -Class II, Molecular (2L) Platelet Antibody Other Race: Myeloid cells (lineage-specific cell sorting) 1-cells (lineage-specific cell sorting) Molecular for Solid Tumors (See Sample Requirements) with Interp and Report ADDITIONAL TESTS OR COMMENTS 18q LOH (Colon Ca) BRAE mutation (exons 11 or 15) CTNNB1 EGFR mutation Httn://www.mdanderson.oraMetrisionthOlOgvihematoDatholonv/index.htM K/T (exon 9, 11, 13, 17) KRAS mutation (codon12, 13,61) Microsatellite Instability NRAS mutation PDGFRA mutation MU-11 Promoter Methylation CYTOGENETICS Conventional chromosome analysis Fluorescence in situ hybridization (FISH) Specify Probe: DISCLOSURE Disclosure of your social security number (SSN) is requested from you In order for The University of Texas M.D. Anderson Cancer Center to process your request for diagnostic services. No statute or other authority requires that you disclose your SSN for this purpose and we may not deny services if you choose not to disclose it Failure to provide your SSN, however, may result In the creation of a duplicate patient number being Issued, which may lead to multiple medical records. Further disclosure of your SSN is governed by the Texas Public Information Act and other applicable law. For questions related to the above Information call at (WO) 3154424 or Fax (713) 745-1994. -REV. 4111/218

U.T. MD ANDERSON CANCER CENTER DIVISION OF PATHOLOGY AND LABORATORY MEDICINE ADMISSIONS AND NEW PATIENT REGISTRATION Blood Tissue Slides MR # REGISTRATION REQUEST PATIENT INFORMATION PATIENT NAME: PATIENT'S ADDRESS: PATIENT'S PHONE: PATIENT'S DATE OF BIRTH: PATIENT'S SOCIAL SECURITY PATIENT'S SEX: PATIENT'S MARITAL STATUS: PRIMARY INSURANCE *will fax face sheet if secondary insurance is listed INSURANCE COMPANY: POLICY it: ADDRESS: GROUP PLAN NAME: TELEPHONE#: EFFECTIVE DATE: GROUP PLAN It: INSURED'S NAME (if different from patient): RELATIONSHIP TO PATIENT: INSURED'S SS#: INSURED'S DOB: GUARANTOR INFORMATION SELF: OTHER: (NAME) (ADDRESS) (PHONE) MDACC SERVICE CODE: MDACC PHYSICIAN CODE: CONSULT REQUESTED BY: PH# : Disclosure of your social security number (SSN) is requested from you in order for The University of Texas M.D. Anderson Cancer Center to process your request for diagnostic services. No statute or other authority requires that you disclose your SSN for this purpose and we may not deny services if you choose not to disclose it. Failure to provide your SSN, however, may result in the creation of a duplicate patient number being issued, which may lead to multiple medical records. Further disclosure of your SSN is governed by the Texas Public Information Act and other applicable law. For questions related to the above information call at (8) 315-8424 or Fax (713) 745-1994. 1/216

(Instructions for Flow Cytometry Testing) Clinical Immunology, Rm. R4.2314, Unit 72 1515 Holcombe Blvd, Houston, Texas 773 INSTRUCTIONS FOR COLLECTION AND SHIPMENT OF PATIENT SPECIMEN FOR FLOW CYTOMETRY TESTING For Bone Marrow Collection: Draw 1-2cc of bone marrow in 1 ml EDTA Tube. For Peripheral Blood Collection: Draw 1 ml of venous peripheral blood, using 1 ml EDTA Tube. Label tubes with the following: Date of Birth Patient's Number (if registered through Department 1-8-315-8424) Initials of Phlebotomist CBC Differential Diagnosis if known Package tubes and requisition form in a suitable mailer, on a cold pack, and ship both to, Laboratory (at address above). Customer/Sender must pay for shipping. Ship via Overnight Delivery Service. Please note that the laboratory is open Monday through Friday 8:am-1pm only. We will not accept delivery on weekends, or holidays. Therefore, coordinate specimen collection and shipping within these days and times. Please contact us if you have any question regarding these instructions. Telephone 713-792-3462 FAX 713-794-5541 Request for Flow Cytometry Testing only should be sent to: UT MD ANDERSON CANCER CENTER Clinical Immunology Lab, Rm. R4.2314, Unit 72 1515 Holcombe Blvd. Houston, Texas 773 1/26/216

(Instructions for Cytogenetics Testing) Cytogenetics Laboratory, Rm. B8.4512, Unit 35 1515 Holcombe Blvd, Houston, Texas 773 INSTRUCTIONS FOR COLLECTION AND SHIPMENT OF PATIENT SPECIMEN FOR CYTOGENETICS TESTING For Bone Marrow Collection: Draw 1-2cc of bone marrow in sodium heparin. For Peripheral Blood Collection: Draw 1-2 ml of venous peripheral blood, using sterile sodium heparin tube (green top). Label tubes with the following: Date of Birth Patient's Number (if registered through Department 1-8-315-8424) Initials of Phlebotomist CBC Differential Diagnosis if known Package tubes and requisition form in a suitable mailer, on a cold pack, and ship both back to, Cytogenetics Laboratory (at address above), using AIRBONE Shipping (Customer/Sender must pay for shipping). Ship via AIRBORNE'S Overnight Delivery Service. Please note that the laboratory is open Monday through Friday 7:am-11pm only. We will not accept delivery on weekends, or holidays. Therefore, coordinate specimen collection and shipping within these days and times. Please contact us if you have any question regarding these instructions. Telephone 713-792-633 FAX 713-745-3215 Request for Cytogenetics Testing only should be sent to: UT MD ANDERSON CANCER CENTER Cytogenetics Laboratory, Room B8.4512, Unit 35 1515 Holcombe Blvd. Houston, Texas 773 1_26_216

(Instructions for HLA Testing) Histocompatibility Laboratory 6565 MD Anderson Blvd Unit#16 Houston, Texas 773 INSTRUCTIONS FOR COLLECTION AND SHIPMENT OF PATIENT SPECIMEN FOR HLA TESTING For Peripheral Blood Collection: Draw venous peripheral blood, using sterile (2) 1 ml EDTA tubes and (1) 1 ml ACD tube for HLA Testing. For Patient's Only: Draw above tubes and include an additional (1) 7 ml Non-Gel tube for Antibody Testing Of needed) Label tubes with the following: Date of Birth Patient's Number (if registered through Department 1-8-315-8424) Initials of Phlebotomist Package tubes and requisition form in a suitable mailer, at room temperature, and ship both back to, HLA Laboratory (at address above), using UPS Shipping (Customer/Sender must pay for shipping). Ship via UPS' Overnight Delivery Service. Please note that the laboratory is open Monday through Friday 7:3 am - 9:3 pm only. We will not accept delivery on weekends, or holidays. Therefore, coordinate specimen collection and shipping within these days and times. Please contact us if you have any question regarding these instructions. Telephone 713-792-2658 FAX 713-794-4773 Request for HLA Testing Only should be sent to: UT M. D. ANDERSON CANCER CENTER 6565 MD Anderson Blvd Houston, Texas 773 Instructions 1_26_2E6

(Instructions for Molecular Testing) Molecular Diagnostics Laboratory 6565 MD Anderson Blvd Unit# 162 Houston, Texas 773 Collection and Transport of Specimens for Molecular Testing To ensure optimum testing conditions for a specimen that is sent to the Molecular Diagnostics Laboratory (MDL) at MD Anderson Cancer Center (MDACC), the client should follow the below guidelines: 1. For *Peripheral Blood, collect 1-2 ml venous blood in EDTA (purple-top) vacutainer tubes. For *Bone Marrow, collect 1-3 ml in EDTA. It is important that a non-heparinized syringe is used for the initial bone marrow collection; then transferring the specimen to the sterile EDTA vacutainer tube without using a needle to dispense the sample. For *Solid Tumor testing, send 5-6 slides containing bum sections of paraffinembedded tissue, along with a guide H&E-stained section. For 18q LOH/MSI studies, also have separate normal and tumor sections or indication of normal and tumor areas if on the same slide. A paraffin block can also be sent. Send at room temperature. Consult with lab for additional questions. 2 Identify the specimen(s) to be sent to MDL: Date of Birth (DOB) Patient's MDACC# (if available) Initials of Phlebotomist. All EDTA tubes should be refrigerated immediately after collection and shipped with cold pack by overnight courier. *Extracted RNA or cdna should be shipped frozen on thy ice. Samples should be shipped by overnight carrier to arrive Tuesday- Friday by 4:PM. Call 713-794-478 for additional information. Sender is responsible for shipping charges. *Shipping Address: Molecular Diagnostics Laboratory 6565 MD Anderson Blvd Unit# 162 Houston, Texas 773 1/26/216